Medication Utilization Among Children With Sickle Cell Disease in the United States
Our study findings underscore the dynamic nature of SCD management in children, and highlight the need for continuous evaluation of treatment guideline adherence, as well as treatment effectiveness and safety with the newer SCD medications and treatment guidelines, to optimize clinical outcomes among this vulnerable patient population.
Authors
- Meghan McCormick (ORCID: https://orcid.org/0000-0003-3633-6369)
- Mary L. Greaney (ORCID: https://orcid.org/0000-0002-5963-920X)
- Kelly L. Matson (ORCID: https://orcid.org/0000-0001-7960-690X)
- Aisling R. Caffrey (ORCID: https://orcid.org/0000-0002-4180-027X)
- Abiodun Ologunowa (ORCID: https://orcid.org/0009-0004-9752-2020)
- Jung Eun Lee (ORCID: https://orcid.org/0000-0001-7807-2838)
Institutions
- UMass Memorial Health Care (US)
- University of Rhode Island (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1002/pbc.31788
- Citations
- 1
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.63